- Home
- NLSP vs ADN Comparison
NLSP vs ADN Comparison
Compare NLSP & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- ADN
- Stock Information
- Founded
- NLSP 2015
- ADN 2006
- Country
- NLSP Switzerland
- ADN United States
- Employees
- NLSP N/A
- ADN N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- ADN Power Generation
- Sector
- NLSP Health Care
- ADN Utilities
- Exchange
- NLSP Nasdaq
- ADN Nasdaq
- Market Cap
- NLSP 5.8M
- ADN 6.6M
- IPO Year
- NLSP 2021
- ADN N/A
- Fundamental
- Price
- NLSP $2.30
- ADN $2.90
- Analyst Decision
- NLSP
- ADN
- Analyst Count
- NLSP 0
- ADN 0
- Target Price
- NLSP N/A
- ADN N/A
- AVG Volume (30 Days)
- NLSP 423.9K
- ADN 23.4K
- Earning Date
- NLSP 06-17-2025
- ADN 12-27-2024
- Dividend Yield
- NLSP N/A
- ADN N/A
- EPS Growth
- NLSP N/A
- ADN N/A
- EPS
- NLSP N/A
- ADN N/A
- Revenue
- NLSP N/A
- ADN $3,276,000.00
- Revenue This Year
- NLSP N/A
- ADN $2,232.99
- Revenue Next Year
- NLSP N/A
- ADN $91.56
- P/E Ratio
- NLSP N/A
- ADN N/A
- Revenue Growth
- NLSP N/A
- ADN 274.35
- 52 Week Low
- NLSP $1.30
- ADN $1.71
- 52 Week High
- NLSP $18.39
- ADN $8.79
- Technical
- Relative Strength Index (RSI)
- NLSP 65.15
- ADN 55.41
- Support Level
- NLSP $1.58
- ADN $2.52
- Resistance Level
- NLSP $2.39
- ADN $2.74
- Average True Range (ATR)
- NLSP 0.23
- ADN 0.26
- MACD
- NLSP 0.02
- ADN 0.07
- Stochastic Oscillator
- NLSP 89.29
- ADN 84.51
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.